Pasithea Total Assets from 2010 to 2024

KTTAW Stock

USD 0.02 0 11.11%

Pasithea Therapeutics Total Assets yearly trend continues to be fairly stable with very little volatility. Total Assets are likely to outpace its year average in 2024. Total Assets is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. View All Fundamentals

Total Assets

First Reported

2010-12-31

Previous Quarter

26.1 M

Current Value

34.3 M

Quarterly Volatility

18.9 M

Credit Downgrade

Yuan Drop

Covid

Check Pasithea Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pasithea Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 680.9 K, Other Operating Expenses of 9.9 M or Total Operating Expenses of 9.8 M, as well as many indicators such as Price To Sales Ratio of 36.39, Dividend Yield of 0.0 or PTB Ratio of 0.38. Pasithea financial statements analysis is a perfect complement when working with Pasithea Therapeutics Valuation or Volatility modules.

Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Latest Pasithea Therapeutics' Total Assets Growth Pattern

Below is the plot of the Total Assets of Pasithea Therapeutics Corp over the last few years. Total assets refers to the total amount of Pasithea Therapeutics assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Pasithea Therapeutics books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. It is the total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets. Pasithea Therapeutics' Total Assets historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pasithea Therapeutics' overall financial position and show how it may be relating to other accounts over time.

View

Last Reported 26.12 M

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Total Assets

Timeline

Pasithea Total Assets Regression Statistics

	Arithmetic Mean	10,778,872
	Geometric Mean	950,998
	Coefficient Of Variation	175.39
	Mean Deviation	15,445,340
	Median	247,958
	Standard Deviation	18,904,703
	Sample Variance	357.4T
	Range	53.1M
	R-Value	0.70
	Mean Square Error	195.3T
	R-Squared	0.49
	Significance	0
	Slope	2,967,125
	Total Sum of Squares	5003.4T

Pasithea Total Assets History

	2024	34.3 M
	2023	26.1 M
	2022	45.2 M
	2021	53.3 M

Other Fundumenentals of Pasithea Therapeutics

Intangibles To Total Assets

Pasithea Therapeutics Total Assets component correlations

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Total Liab	Net Invested Capital	Total Current Assets	Capital Stock	Net Working Capital	Common Stock	Current Deferred Revenue	Net Receivables	Short Term Debt	Intangible Assets
Total Assets		1.0	-0.96	-0.63	0.68	0.91	1.0	0.99	-0.25	0.98	-0.25	-0.42	-0.42	-0.41	-0.41
Total Stockholder Equity	1.0		-0.97	-0.61	0.67	0.9	1.0	0.99	-0.23	0.98	-0.23	-0.41	-0.4	-0.39	-0.4
Net Debt	-0.96	-0.97		0.42	-0.48	-0.8	-0.97	-0.98	0.05	-0.99	0.05	0.22	0.22	0.22	0.2
Retained Earnings	-0.63	-0.61	0.42		-1.0	-0.86	-0.61	-0.52	0.85	-0.48	0.85	0.91	0.92	0.92	0.79
Accounts Payable	0.68	0.67	-0.48	-1.0		0.88	0.67	0.58	-0.83	0.55	-0.83	-0.91	-0.91	-0.9	-0.81
Total Liab	0.91	0.9	-0.8	-0.86	0.88		0.9	0.84	-0.5	0.81	-0.5	-0.64	-0.65	-0.66	-0.51
Net Invested Capital	1.0	1.0	-0.97	-0.61	0.67	0.9		0.99	-0.23	0.98	-0.23	-0.41	-0.4	-0.39	-0.4
Total Current Assets	0.99	0.99	-0.98	-0.52	0.58	0.84	0.99		-0.16	1.0	-0.16	-0.34	-0.33	-0.32	-0.36
Capital Stock	-0.25	-0.23	0.05	0.85	-0.83	-0.5	-0.23	-0.16		-0.13	1.0	0.98	0.98	0.98	0.86
Net Working Capital	0.98	0.98	-0.99	-0.48	0.55	0.81	0.98	1.0	-0.13		-0.13	-0.31	-0.3	-0.28	-0.34
Common Stock	-0.25	-0.23	0.05	0.85	-0.83	-0.5	-0.23	-0.16	1.0	-0.13		0.98	0.98	0.98	0.86
Current Deferred Revenue	-0.42	-0.41	0.22	0.91	-0.91	-0.64	-0.41	-0.34	0.98	-0.31	0.98		1.0	0.98	0.91
Net Receivables	-0.42	-0.4	0.22	0.92	-0.91	-0.65	-0.4	-0.33	0.98	-0.3	0.98	1.0		0.99	0.88
Short Term Debt	-0.41	-0.39	0.22	0.92	-0.9	-0.66	-0.39	-0.32	0.98	-0.28	0.98	0.98	0.99		0.82
Intangible Assets	-0.41	-0.4	0.2	0.79	-0.81	-0.51	-0.4	-0.36	0.86	-0.34	0.86	0.91	0.88	0.82

Click cells to compare fundamentals

About Pasithea Therapeutics Financial Statements

Pasithea Therapeutics investors use historical fundamental indicators, such as Pasithea Therapeutics' Total Assets, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Pasithea Therapeutics. Please read more on our technical analysis and fundamental analysis pages.

	Last Reported	Projected for Next Year
Total Assets	26.1 M	34.3 M
Intangibles To Total Assets	0.35	0.23

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

F	Ford Motor
GOOG	Alphabet Inc Class C
CRM	Salesforce

Additional Tools for Pasithea Stock Analysis

When running Pasithea Therapeutics' price analysis, check to measure Pasithea Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pasithea Therapeutics is operating at the current time. Most of Pasithea Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pasithea Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pasithea Therapeutics' price. Additionally, you may evaluate how the addition of Pasithea Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC